Shanghai Haoyuan Chemexpress Co (SHSE:688131) Interest Expense : ¥-31 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shanghai Haoyuan Chemexpress Co's interest expense for the three months ended in Dec. 2024 was ¥ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ¥-31 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shanghai Haoyuan Chemexpress Co's Operating Income for the three months ended in Dec. 2024 was ¥ 154 Mil. Shanghai Haoyuan Chemexpress Co's Interest Expense for the three months ended in Dec. 2024 was ¥ -10 Mil. Shanghai Haoyuan Chemexpress Co's Interest Coverage for the quarter that ended in Dec. 2024 was 16.00. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Haoyuan Chemexpress Co Interest Expense Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Interest Expense Chart

Shanghai Haoyuan Chemexpress Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-2.63

-9.50

-7.63

-23.70

-31.33

Shanghai Haoyuan Chemexpress Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-9.26	-6.73	-12.82	-2.15	-9.64

Shanghai Haoyuan Chemexpress Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-31 Mil.

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Haoyuan Chemexpress Co's Interest Expense for the three months ended in Dec. 2024 was ¥-10 Mil. Its Operating Income for the three months ended in Dec. 2024 was ¥154 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ¥1,247 Mil.

Shanghai Haoyuan Chemexpress Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	154.201	/	-9.636
	=	16.00

The higher the ratio, the stronger the company's financial strength is.

Shanghai Haoyuan Chemexpress Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.chemexpress.com.cn

Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.

Executives

Mei Kui

Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines